title: Third-trimester uterine rupture after prostaglandin E2 use for labor induction.
abstract: Prostaglandin E2 is a powerful oxytoxic agent that reliably initiates labor, even in the presence of an unripened cervix. The very low incidence of obstetric and neonatal side effects contributes to its universal use. Only nine cases of uterine rupture during the third trimester of pregnancy after application of various prostaglandin E2 preparations have been reported in English. Although uterine rupture after prostaglandin administration is a very rare complication, no prostaglandin compound seems to be exempt from it.
authors.affiliation: Department of Obstetrics and Gynecology B, Sapir Medical Center, Kfar Saba, Israel.
authors.forename: R
authors.initials: R
authors.lastname: Maymon
authors.forename: L
authors.initials: L
authors.lastname: Haimovich
authors.forename: A
authors.initials: A
authors.lastname: Shulman
authors.forename: M
authors.initials: M
authors.lastname: Pomeranz
authors.forename: M
authors.initials: M
authors.lastname: Holtzinger
authors.forename: C
authors.initials: C
authors.lastname: Bahary
mesh_terms: D000328:Adult; D002585:Cesarean Section / Q000706:statistics & numerical data; D004359:Drug Therapy, Combination; D005260:Female; D005865:Gestational Age; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data; D015994:Incidence; D007751:Labor, Induced / Q000009:adverse effects* / Q000379:methods; D008428:Maternal Mortality; D010121:Oxytocin / Q000008:administration & dosage; D010298:Parity; D011247:Pregnancy; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D011458:Prostaglandins E / Q000008:administration & dosage / Q000009:adverse effects*; D014597:Uterine Rupture / Q000139:chemically induced* / Q000453:epidemiology / Q000601:surgery
chemical_list: D011458:Prostaglandins E; D010121:Oxytocin